3Ng CS, Wang S, Yim AP,et al. Pulmonary dysfunction after cardiac surgery[J]. Chest,2002,121 (4) : 1269-1277.
4Sievers H, Freand K, Eleftheriadis S,et al. Lung protection during total cardiopulmonary bypass byisolated lung perfusion: result so fanovel perfusions trategy[ J]. Ann Thorac,2003,76(2) :516 -521.
5Massoudy P, Zahler S, Becker BF,et al. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass[ J]. Chest,2001,119( 1 ) :31 - 36.
6Giomarelli P, Scolletta S, Borrelli E, et al. Myocardial and lung injury after eardiopulmonary bypass:role finterleukin (IL)-10 [ J ]. Ann Thorac Surg,2003,76( 1 ) :117 - 123.
7Sievers H, Freund kass C, Eleftheriadis S,et al. Lung protect on during total cardiopul monary bypass by isolated lung perfusi on:preliminary results of a novel perfusion strategy [ J ]. Ann Thorac Surg, 2002,74 (4) :1167 - 1172.
8Jegger D, Ruchat P, Horisberger J, et al. A cardiopulmonary bypass score system to assess quality of perfusion performance [J]. Perfusion,2001,15(3) :183 -188.
9于军.体外循环面临的挑战与对策[M].北京:中国协和医科大学出版社,2003.12.
10Nashef SA,Roques F, Michel P, et al. European system for cardiac operative risk evaluation(EuroSCORE). Eur J Cardiothorac Surg, 1999,16 ( 1 ) :9 - 13.
